TY  - GEN
AU  - Patnaik,Amita
AU  - Kang,S Peter
AU  - Rasco,Drew
AU  - Papadopoulos,Kyriakos P
AU  - Elassaiss-Schaap,Jeroen
AU  - Beeram,Muralidhar
AU  - Drengler,Ronald
AU  - Chen,Cong
AU  - Smith,Lon
AU  - Espino,Guillermo
AU  - Gergich,Kevin
AU  - Delgado,Liliana
AU  - Daud,Adil
AU  - Lindia,Jill A
AU  - Li,Xiaoyun Nicole
AU  - Pierce,Robert H
AU  - Yearley,Jennifer H
AU  - Wu,Dianna
AU  - Laterza,Omar
AU  - Lehnert,Manfred
AU  - Iannone,Robert
AU  - Tolcher,Anthony W
TI  - Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
SN  - 1557-3265
PY  - 2016///0711
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - pharmacology
KW  - Antineoplastic Agents
KW  - Drug Monitoring
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Neoplasm Staging
KW  - Neoplasms
KW  - drug therapy
KW  - Programmed Cell Death 1 Receptor
KW  - antagonists & inhibitors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-14-2607
ER  -